ALDX
Price
$1.42
Change
-$3.90 (-73.31%)
Updated
Apr 3 closing price
Capitalization
84.79M
27 days until earnings call
CLLS
Price
$1.20
Change
-$0.06 (-4.76%)
Updated
Apr 3 closing price
Capitalization
168.42M
33 days until earnings call
Ad is loading...

ALDX vs CLLS

Header iconALDX vs CLLS Comparison
Open Charts ALDX vs CLLSBanner chart's image
Aldeyra Therapeutics
Price$1.42
Change-$3.90 (-73.31%)
Volume$22.27M
Capitalization84.79M
Cellectis SA
Price$1.20
Change-$0.06 (-4.76%)
Volume$108.23K
Capitalization168.42M
ALDX vs CLLS Comparison Chart
Loading...
ALDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALDX vs. CLLS commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALDX is a Buy and CLLS is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (ALDX: $1.42 vs. CLLS: $1.22)
Brand notoriety: ALDX and CLLS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALDX: 1909% vs. CLLS: 26%
Market capitalization -- ALDX: $84.79M vs. CLLS: $168.42M
ALDX [@Biotechnology] is valued at $84.79M. CLLS’s [@Biotechnology] market capitalization is $168.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALDX’s FA Score shows that 0 FA rating(s) are green whileCLLS’s FA Score has 1 green FA rating(s).

  • ALDX’s FA Score: 0 green, 5 red.
  • CLLS’s FA Score: 1 green, 4 red.
According to our system of comparison, both ALDX and CLLS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALDX’s TA Score shows that 5 TA indicator(s) are bullish while CLLS’s TA Score has 4 bullish TA indicator(s).

  • ALDX’s TA Score: 5 bullish, 4 bearish.
  • CLLS’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both ALDX and CLLS are a good buy in the short-term.

Price Growth

ALDX (@Biotechnology) experienced а -77.32% price change this week, while CLLS (@Biotechnology) price change was -6.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.91%. For the same industry, the average monthly price growth was -11.19%, and the average quarterly price growth was -14.86%.

Reported Earning Dates

ALDX is expected to report earnings on May 01, 2025.

CLLS is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-8.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLLS($168M) has a higher market cap than ALDX($84.8M). CLLS YTD gains are higher at: -33.333 vs. ALDX (-71.543). CLLS has higher annual earnings (EBITDA): -9.46M vs. ALDX (-53.68M). CLLS has more cash in the bank: 260M vs. ALDX (101M). ALDX has less debt than CLLS: ALDX (15.3M) vs CLLS (91.5M). CLLS has higher revenues than ALDX: CLLS (41.5M) vs ALDX (0).
ALDXCLLSALDX / CLLS
Capitalization84.8M168M50%
EBITDA-53.68M-9.46M567%
Gain YTD-71.543-33.333215%
P/E RatioN/AN/A-
Revenue041.5M-
Total Cash101M260M39%
Total Debt15.3M91.5M17%
FUNDAMENTALS RATINGS
ALDX vs CLLS: Fundamental Ratings
ALDX
CLLS
OUTLOOK RATING
1..100
661
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
23
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
5185
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLLS's Valuation (23) in the Biotechnology industry is in the same range as ALDX (26). This means that CLLS’s stock grew similarly to ALDX’s over the last 12 months.

CLLS's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ALDX (100). This means that CLLS’s stock grew similarly to ALDX’s over the last 12 months.

CLLS's SMR Rating (97) in the Biotechnology industry is in the same range as ALDX (98). This means that CLLS’s stock grew similarly to ALDX’s over the last 12 months.

ALDX's Price Growth Rating (51) in the Biotechnology industry is somewhat better than the same rating for CLLS (85). This means that ALDX’s stock grew somewhat faster than CLLS’s over the last 12 months.

ALDX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as CLLS (100). This means that ALDX’s stock grew similarly to CLLS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALDXCLLS
RSI
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 11 days ago
84%
Bullish Trend 12 days ago
78%
Declines
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
84%
N/A
Aroon
ODDS (%)
Bullish Trend 5 days ago
89%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Ad is loading...
ALDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BPTSY3.36N/A
N/A
Biophytis SA
SMGZY25.31-0.13
-0.51%
Smiths Group Plc
POAHY3.61-0.07
-1.90%
Porsche Automobile Holding SE
ISNPY29.57-1.73
-5.53%
Intesa Sanpaolo S.p.A.
GLASF4.58-0.31
-6.41%
Glass House Brands Inc.

ALDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALDX has been loosely correlated with IOVA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ALDX jumps, then IOVA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALDX
1D Price
Change %
ALDX100%
-73.33%
IOVA - ALDX
47%
Loosely correlated
-8.19%
CANF - ALDX
46%
Loosely correlated
-0.66%
ABSI - ALDX
41%
Loosely correlated
-9.88%
CMVLF - ALDX
39%
Loosely correlated
N/A
CLLS - ALDX
39%
Loosely correlated
-4.76%
More

CLLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLLS has been closely correlated with CMVLF. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if CLLS jumps, then CMVLF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLLS
1D Price
Change %
CLLS100%
-4.76%
CMVLF - CLLS
82%
Closely correlated
N/A
ABCZF - CLLS
58%
Loosely correlated
N/A
SLN - CLLS
43%
Loosely correlated
-5.19%
MDGL - CLLS
40%
Loosely correlated
-2.24%
PMVP - CLLS
38%
Loosely correlated
-0.50%
More